Intervention

eicosapentaenoic acid

ClinicalTrials.gov intervention label

Clinical trials3

Recruiting0

Common conditions4

Lead sponsors shown3

Clinical trials

3 shown

Eicosapentaenoic Acid Serum Levels in Patients With Gestational DiabetesNCT05591664 · 2022-10-17

Safety and Effectiveness of Omega 3-Fatty Acids, EPA Versus DHA, for the Treatment of Major DepressionNCT00361374 · 2006-07-01

Ethyl-Eicosapentaenoic Acid and Tardive DyskinesiaNCT00114595 · 2003-04-01

Common conditions

Dyskinesia1 Gestational Diabetes1 Major Depressive Disorder1 Schizophrenia1

Leading sponsors

Massachusetts General Hospital1 Recep Tayyip Erdogan University Training and Research Hospital1 University of Stellenbosch1

Trial status mix

COMPLETED2

UNKNOWN1

Phase mix

PHASE31

PHASE41

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.